TEMETEX 1 мг/г Крем

Содержание инструкции

1. TEMETEX 1 mg/g hydrophilic cream
   1. What Temetex is and what it is used for
   2. What you need to know before using Temetex
   3. How to use Temetex
   4. Possible side effects
   5. How to store Temetex
   6. Contents of the pack and other information
2. TEMETEX 1 mg/g hydrophobic cream
   1. What Temetex is and what it is used for
   2. What you need to know before using Temetex
   3. How to use Temetex
   4. Possible side effects
   5. How to store Temetex
   6. Contents of the pack and other information
3. TEMETEX 3 mg/g hydrophobic cream
   1. What is Temetex and what is it used for?
   2. What you need to know before using Temetex
   3. How to use Temetex
   4. Possible side effects
   5. How to store Temetex
   6. Contents of the pack and other information

TEMETEX 1 mg/g hydrophilic cream

Diflucortolone

Read this leaflet carefully before you start to use this medicine as it contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it may be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor. See section 4.

Contents of this leaflet:

• 1. What Temetex is and what it is used for
• 2. What you need to know before you use Temetex
• 3. How to use Temetex
• 4. Possible side effects
• 5. How to store Temetex
• 6. Contents of the pack and other information

1. What Temetex is and what it is used for

Temetex contains the active ingredient diflucortolone, belonging to the class of topical
corticosteroid drugs. It is indicated for the treatment of some skin diseases of an
inflammatory and allergic nature such as contact eczema, contact dermatitis (of allergic or
toxic nature such as hypersensitivity to detergents or other chemical agents), common eczema (acute and chronic phase),
microbial eczema, dermoepidermitis, seborrheic eczema, varicose eczema (however not
directly on the ulcer), eczema in children, anal eczema.

2. What you need to know before using Temetex

Do not use Temetex:

• If you are allergic to the active ingredient or to any of the other ingredients of this medicine (listed in section 6).
• In the presence, in the area to be treated, of skin lesions secondary to vaccination, tuberculosis, fungal, bacterial or viral infections (herpes, varicella etc), rosacea acne and skin ulcers. The preparation is not for ophthalmic use.
• Occlusive dressing (bandaging with gauze or other material to maintain medicines applied to the skin locally) is contraindicated in exudative lesions (i.e. with the presence of fluid resulting from inflammation) and skin infections.

Warnings and precautions
In skin diseases accompanied by bacterial infections, it is appropriate to associate a treatment
with chemotherapeutic agents for local use; in case of mycosis (fungal infection) local antimycotics are
necessary. Temetex is not indicated in the treatment of eye diseases.
Temetex should not be applied to the eyes. If applying the product to the face, avoid contact with the
eyes. Application of corticosteroids to the skin in the treatment of
extensive and/or long-term skin diseases (dermatoses) can determine secondary phenomena of systemic
absorption, thus leading to the onset of hormonal disorders (Cushing's syndrome, inhibition of the
hypothalamic-pituitary axis). This event is more frequent in children and
in case of occlusive bandaging.
In pediatric use, skin folds and diapers can act as an occlusive dressing.
Therefore, in the treatment of chronic conditions requiring prolonged therapies, if a favorable therapeutic
effect has been achieved, it will be appropriate to reduce the dosage and frequency of
applications to the minimum necessary to control the symptoms and avoid relapses by suspending the use
of the preparation as soon as possible.
During therapy, it is necessary to monitor the patient's condition in order to detect
early signs and symptoms of steroid excess (asthenia (fatigue), high blood pressure,
electrolyte disturbances (alteration of the amount of some minerals present in the blood, etc.)). In all
cases, it is appropriate to limit the use of topical steroids (i.e. for local application) to short periods of
time.
Contact your doctor if you experience blurred vision or other visual disturbances.

Children
In infants and children under four years of age, treatment for periods
longer than three weeks is not recommended, especially in areas covered by diapers. (See “ warnings and

precautions”).

Other medicines and Temetex
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicine.
No known possible interactions and incompatibilities with other medicines have been reported.

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding
with breast milk, ask your doctor or pharmacist for advice before taking this medicine.
Local application of corticosteroids to pregnant laboratory animals can induce the occurrence of
fetal malformations. The transferability of these data to humans has not been demonstrated. In general, for
topical preparations (i.e. for local use) containing corticosteroids, such as Temetex, use is not
recommended during the first trimester of pregnancy. In particular, application of
the product to extensive skin areas or for prolonged periods should be avoided .
In pregnant women, Temetex should only be used in case of actual need and
under the direct control of the doctor.

Driving and operating machinery
Temetex does not impair the ability to drive vehicles or operate machinery.

Temetex contains parabens and stearyl alcohol
This medicine contains methyl p-hydroxybenzoate and propyl p-hydroxybenzoate which may
cause allergic reactions (including delayed reactions).
This medicine contains stearyl alcohol which may cause localized skin reactions (e.g. contact dermatitis).

3. How to use Temetex

Use this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, consult your doctor or pharmacist.
Unless otherwise prescribed by your doctor, start treatment by applying the preparation in a thin layer 2-3
times a day. As soon as the clinical picture improves, a single daily application is sufficient.
Due to its particular composition (a non-greasy “oil in water” emulsion), Temetex is
particularly indicated in the treatment of exuding lesions and moist skin areas, such as the
anal region and the armpit, where it is appropriate to use a base with a high water content.
Temetex hydrophilic cream allows the secretion to flow and induces rapid exudation (i.e. a
rapid passage from the smallest blood vessels and collection of the liquid material produced
by inflammation of the tissues) and drying of the skin.
The preparation does not leave a greasy residue on the skin and is therefore also suitable for application to the
face and exposed skin areas.

Use in children
In infants and children under 4 years of age, treatment for periods longer than
three weeks is not recommended, especially in areas covered by diapers.

If you take more Temetex than you should:
In case of ingestion/accidental intake of an excessive dose of Temetex, immediately inform
your doctor or go to the nearest hospital. No cases of overdose are known.

If you forget to use Temetex
Do not take a double dose to make up for a missed dose.

If you stop using Temetex
If you have any doubts about the use of Temetex, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects that may occur with the use of this medicine include:
Locally redness, edema (swelling), desquamation (loss of the upper layer of the
skin), itching as signs of hypersensitivity to the medicine. Other effects include hypertrichosis
(increased growth of body hair), acneiform eruptions (similar to acne), skin atrophy
(reduction in skin volume), hypopigmentation (decreased skin color),
telangiectasias (dilation of small blood vessels that become visible under the skin), striae,
vascular fragility, purpura (reddish discoloration of the skin due to small blood leakage from the
capillaries), blurred vision (uncommon frequency known, the frequency cannot be defined on the
basis of available data).
After prolonged treatments (especially on the face) rebound pustular dermatoses (skin manifestations
that resemble blisters and appear when the drug is stopped) which, being
sensitive to steroids, such as Temetex, become evident only when the
therapy is discontinued.
During treatment of extensive skin areas (about 10% or more of the body surface) and/or of
prolonged use (more than 4 weeks) especially under occlusive dressing, it is not possible to
exclude, as with all other topical corticosteroids, the following concomitant reactions: skin atrophies
(loss of the upper layer of the skin), telangiectasias (dilation of small blood vessels that
become visible under the skin), striae, acneiform manifestations (similar to acne), perioral dermatitis
(inflammation of the skin around the mouth), increased growth of body hair (hypertrichosis).
Systemic symptoms (i.e. that can manifest throughout the body, for example as hormonal disorders) from
cutaneous absorption of corticosteroids. In occlusive treatmentskeep in mind
that the films used for dressing can themselves cause sensitization phenomena. The use, especially if
prolonged, of products for topical use, can give rise to sensitization phenomena. In this case it is
necessary to interrupt the treatment and establish an adequate therapy.
In predisposed subjects, hypersensitivity reactions may occur.

Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your
doctor. You can also report side effects directly through the national reporting system at:
https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects you can help provide more information on the safety
of this medicine.

5. How to store Temetex

Keep this medicine out of the sight and reach of children.
Temetex does not require any particular precautions for storage.
Do not use this medicine after the expiry date stated on the packaging after Scad. The expiry date refers to the last day of that month.
The expiry date refers to the product in intact packaging, correctly stored.
Do not use this medicine if you notice visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your
pharmacist how to dispose of medicines you no longer use. This will help protect the environment.

6. Contents of the pack and other information

What Temetex contains
100 g of cream contains:

Active substance: diflucortolone valerate 0.1 g.

Other components: polyethylene glycol monostearate, stearyl alcohol, liquid paraffin, white petrolatum,
disodium edetate, carbomer, sodium hydroxide, methyl parahydroxybenzoate, propyl
parahydroxybenzoate, purified water.

Description of the appearance of Temetex and contents of the pack
Temetex 1 mg/g hydrophilic cream appears as a white or slightly yellowish cream for local use
packaged in a 30 g tube.

Marketing authorisation holder and manufacturer:

Marketing authorisation holder
TEOFARMA S.r.l.
Via F.lli Cervi, 8
27010 Valle Salimbene (PV)

Manufacturer
TEOFARMA S.r.l.
Viale Certosa, 8/A
27100 Pavia

TEMETEX 1 mg/g hydrophobic cream

Diflucortolone

Read this leaflet carefully before you start using this medicine as it contains important
information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others, even if they have the same symptoms as you, as it may be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor. See section 4.

Contents of this leaflet:

• 1. What Temetex is and what it is used for
• 2. What you need to know before you use Temetex
• 3. How to use Temetex
• 4. Possible side effects
• 5. How to store Temetex
• 6. Contents of the pack and other information

1. What Temetex is and what it is used for

Temetex contains the active ingredient diflucortolone, belonging to the class of topical corticosteroid drugs. It is used for the treatment of contact eczema, contact dermatitis (of allergic or toxic nature such as hypersensitivity to detergents or other chemical agents), common eczema (acute and chronic phase), microbial eczema, dermoepidermitis, seborrheic eczema, varicose eczema (however not directly on the ulcer), eczema in children, anal eczema.

2. What you need to know before using Temetex

Do not use Temetex:

• If you are allergic to the active ingredient or any of the other ingredients of this medicine (listed in section 6).
• In the presence, in the area to be treated, of skin lesions secondary to vaccination, tuberculosis, fungal, bacterial or viral infections (herpes, chickenpox etc), rosacea acne and skin ulcers. The preparation is not for ophthalmic use.
• Occlusive dressings are contraindicated in exudative lesions and skin infections.

Warnings and precautions
In skin diseases accompanied by bacterial infections, it is appropriate to associate a
treatment with topical chemotherapeutic agents; in case of fungal infections, local antimycotics are necessary.
Temetex is not indicated in the treatment of eye diseases.
Temetex should not be applied to the eyes. If applying the product to the face, avoid contact with the
eyes.
The cutaneous application of corticosteroids in the treatment of extensive and/or prolonged
skin conditions can determine secondary systemic absorption phenomena. This is more frequent in children and in case of occlusive bandaging. In pediatric use, skin folds
and diapers can act as occlusive dressings. Therefore, in the treatment of chronic conditions
requiring prolonged therapies, once a favorable therapeutic effect has been achieved
it will be appropriate to reduce the dosage and frequency of applications to the minimum
necessary to control symptoms and avoid relapses, stopping the use of the preparation as soon as
possible.
During therapy it is necessary to monitor the patient's condition in order to highlight
early signs and symptoms of steroid excess (asthenia, hypertension, electrolyte disturbances
etc.). In all cases, it is appropriate to limit the use of topical steroids to short periods of time.
Contact your doctor if you experience blurred vision or other visual disturbances.

Children
In infants and children under four years of age, treatment for periods
longer than three weeks is not recommended, especially in areas covered by diapers (see “ warnings and

precautions”).

Other medicines and Temetex
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicine.
No possible interactions and incompatibilities with other medicines are known.

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with
breast milk, ask your doctor or pharmacist for advice before using this medicine.
Local application of corticosteroids to pregnant laboratory animals can induce the appearance of
fetal malformations. The transferability of these data to humans has not been demonstrated.
In general, topical preparations containing corticosteroids are not recommended for use
during the first trimester of pregnancy.
In particular, the application of the product to extensive skin areas or for prolonged periods should be avoided .
In pregnant women, Temetex should be used only when absolutely necessary, under the direct
control of the doctor.

Driving and operating machinery
Temetex does not impair the ability to drive vehicles or operate machinery.

Temetex contains stearyl alcohol
May cause localized skin reactions (e.g. contact dermatitis).

3. How to use Temetex

Use this medicine following the instructions of your doctor or pharmacist exactly. If you have any
doubts, consult your doctor or pharmacist.
Unless otherwise prescribed by your doctor, start treatment by applying a thin layer 2-3 times
a day. As soon as the clinical picture improves, a single daily application is sufficient.
Due to its particular composition (a non-greasy “oil in water” emulsion), Temetex is
particularly indicated in the treatment of exuding lesions and moist skin areas, such as the
anal region and the armpit, where it is appropriate to use a base with a high water content.
The preparation does not leave a greasy residue on the skin and is therefore also suitable for
application to the face and exposed skin areas.

Use in children
In infants and children under 4 years of age, treatment for periods longer than three weeks is not
recommended, especially in areas covered by diapers.

If you use more Temetex than you should:
In case of ingestion/accidental intake of an excessive dose of Temetex hydrophobic cream,
immediately inform your doctor or go to the nearest hospital. No cases of overdose are known.

If you forget to use Temetex
Do not take a double dose to make up for a missed dose.

If you stop using Temetex
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The side effects that may occur with the use of this medicine include:
Redness, swelling (edema), scaling, local itching as signs of hypersensitivity to the
medicine. Other effects include increased body hair growth (hypertrichosis), acneiform
eruptions, thinning of the skin (skin atrophy), changes in skin color
(hypopigmentation), dilation of small blood vessels, generally superficial
(telangiectasias), stretch marks, vascular fragility, purpura, blurred vision (frequency not known, the
frequency cannot be defined based on available data). After prolonged treatments (especially on the
face) rebound pustular dermatites which, being sensitive to steroids, become evident only
upon discontinuation of therapy.
During the treatment of extensive skin areas (10% or more of the body surface area) and/or
prolonged use (more than 4 weeks), especially under occlusive dressing, the following reactions cannot be
excluded, as with all other topical corticosteroids: thinning of the skin (skin atrophies), dilation of small
blood vessels, generally superficial (telangiectasias), stretch marks, acneiform
manifestations, perioral dermatitis, increased body hair growth (hypertrichosis).
Systemic symptoms from skin absorption of corticosteroids.
In occlusive treatments, it should be noted that the films used for dressing may themselves be
the cause of sensitization phenomena. The use, especially if prolonged, of topical products can give rise to
sensitization phenomena.
In this case, it is necessary to discontinue treatment and institute appropriate therapy. In subjects
predisposed, hypersensitivity reactions may occur.

Reporting of side effects
If you get any side effects, even if not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects
directly through the national reporting system at
https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects you can help provide more information on the
safety of this medicine.

5. How to store Temetex

Temetex does not require any particular precautions for storage.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after Scad. The expiry
date refers to the last day of that month.
The expiry date refers to the product in intact packaging, correctly stored.
Do not use this medicine if you notice visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your
pharmacist how to dispose of medicines you no longer use. This will help to protect
the environment.

6. Contents of the pack and other information

What Temetex contains:
100 g of cream contain:

Active ingredient: diflucortolone valerate 0.1 g.

Other components: white beeswax, liquid paraffin, white petrolatum, dehymuls® E (beeswax,
sorbitan, (Z)-9-octadecenoate (2:3), C12-18 fatty acid, mix of esters with citric acid,
pentaerythritol and stearyl alcohol), purified water.

Description of the appearance of Temetex and contents of the pack
Temetex 1mg/g hydrophobic cream is presented in a 30 g tube containing white or
slightly yellowish cream.

Marketing authorisation holder and manufacturer

Marketing authorisation holder
TEOFARMA S.r.l.
Via F.lli Cervi, 8
27010 Valle Salimbene (PV)

Manufacturer
Teofarma S.r.l.
Viale Certosa, 8/A
27100 Pavia

TEMETEX 3 mg/g hydrophobic cream

Diflucortolone

Read this leaflet carefully before you start using this medicine as it contains important
information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others, even if they have the same symptoms as you, as it may be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor. See section 4.

Contents of this leaflet:

• 1. What Temetex is and what it is used for
• 2. What you need to know before you use Temetex
• 3. How to use Temetex
• 4. Possible side effects
• 5. How to store Temetex
• 6. Contents of the pack and other information

1. What is Temetex and what is it used for?

Temetex contains the active ingredient diflucortolone, a corticosteroid for topical use. It is
used for the treatment of localized, resistant plaques of: psoriasis, lichenification, discoid lupus
erythematosus, hypertrophic lichen, hypertrophic scars.

2. What you need to know before using Temetex

Do not use Temetex:

• If you are allergic to the active ingredient or to any of the other ingredients of this medicine (listed in section 6).
• In the presence, in the area to be treated, of skin lesions secondary to vaccination, tuberculosis, fungal, bacterial or viral infections (herpes, varicella etc.), rosacea acne and skin ulcers. The preparation is not for ophthalmic use.

Warnings and precautions
In skin diseases accompanied by bacterial infections, it is appropriate to associate a
treatment with topical chemotherapeutic agents; in case of mycosis, local antimycotics are necessary. Temetex
is not indicated in the treatment of eye diseases.
Temetex should not be applied to the eyes. If the product is applied to the face, avoid contact with the
eyes.
Given the high concentration of the active ingredient, the preparation is not indicated for the treatment of
infants and children under 4 years of age. For the same reason, the product should not be
applied to the face.
Topical application of corticosteroids in the treatment of extensive and/or prolonged dermatoses may determine secondary systemic absorption phenomena. This event
is more frequent in children and in case of occlusive bandaging.
In pediatric use, skin folds and diapers can act as occlusive dressings.
Therefore, in the treatment of chronic conditions requiring prolonged therapies, if a
favorable therapeutic effect has been achieved, it will be appropriate to reduce the dosage and
frequency of applications to the minimum necessary to control symptoms and avoid relapses,
suspending the use of the preparation as soon as possible.
During therapy, it is necessary to monitor the patient's condition in order to detect
early signs and symptoms of steroid excess (asthenia, hypertension, electrolyte disturbances
etc.). In all cases, it is appropriate to limit the use of topical steroids to short periods of time.
Contact your doctor if you experience blurred vision or other visual disturbances.

Children
This medicine is not recommended for infants and children under four years of age
(see “ warnings and precautions”).

Other medicines and Temetex
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicine.
No known possible interactions and incompatibilities with other medicines have been reported.

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning a pregnancy, or if you are breastfeeding with
breast milk, ask your doctor or pharmacist for advice before using this medicine.
Local application of corticosteroids to pregnant laboratory animals can induce the appearance of
fetal malformations. The transferability of these data to humans has not been demonstrated.
In general, topical preparations containing corticosteroids are not recommended for use
during the first trimester of pregnancy.
In particular, the application of the product to extensive skin areas or for prolonged periods should be avoided .
In pregnant women, Temetex should be used only when absolutely necessary, under the direct
supervision of a doctor.

Driving and operating machinery
Temetex does not impair the ability to drive vehicles or operate machinery.

Temetex contains stearyl alcohol
It may cause localized skin reactions (e.g. contact dermatitis).

3. How to use Temetex

Use this medicine following exactly the instructions of your doctor or pharmacist. If you have any
doubts, consult your doctor or pharmacist.
Unless otherwise prescribed by your doctor, start treatment by applying the preparation in a thin layer 2-
3 times a day. This dosage should be observed for a period of 1-2 weeks, during which significant
clinical results are generally observed. As soon as the clinical picture improves, it is sufficient to
reduce the administration to a single daily application or switch to the medicinal product with a lower
concentration (Temetex hydrophobic cream 1mg/g).
In particularly resistant cases, your doctor may prescribe treatment under occlusive dressing. However,
its use on a large body surface is not recommended. If skin infections occur during treatment, it will be
necessary to avoid occlusive dressing for a while. In case of extensive lesions, it is advisable to treat
small areas one at a time in succession.
Due to its particular composition (a slightly oily “oil in water” emulsion), Temetex ensures the
skin an appropriate lipid supply, without blocking perspiration and heat exchange. It therefore
finds possibilities of use both in skin conditions that are not excessively secreting and in those that are
not particularly dry.

If you take more Temetex than you should
In case of accidental ingestion/intake of an excessive dose of Temetex, immediately inform your
doctor or go to the nearest hospital. No cases of overdose are known.

If you forget to use Temetex
Do not take a double dose to make up for a missed dose.

If you stop using Temetex
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
Redness, swelling (edema), scaling, local itching as signs of hypersensitivity to the
medicine. Other effects include vascular fragility, purpura and after prolonged treatments
rebound pustular dermatites which, being sensitive to steroids, become evident only at the
time of discontinuation of therapy. During the treatment of extensive skin areas (10%
or more of the body surface) and/or prolonged use (more than 10 days), especially under
occlusive dressing, the following concomitant reactions cannot be excluded, as with all other
topical corticosteroids: reduction of skin thickness (skin atrophies), changes in skin color
(hypopigmentation), dilation of small blood vessels, generally superficial
(telangiectasias), striae, acneiform manifestations, perioral dermatitis, increased growth of body
hair (hypertrichosis).
Systemic symptoms from skin absorption of corticosteroids.
In occlusive treatments, it should be noted that the films used for dressing may themselves be
cause of sensitization phenomena. The use, especially if prolonged, of products for topical
use, can give rise to sensitization phenomena. In this case it is necessary to interrupt the
treatment and establish adequate therapy.
In predisposed subjects, hypersensitivity reactions may occur.
Frequency not known (frequency cannot be estimated based on available data): blurred
vision.

Reporting of side effects
If you experience any side effects, including those not listed in this leaflet,
tell your doctor or pharmacist. You can also report side effects
directly through the national reporting system at
https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
By reporting side effects you can help provide more information on the
safety of this medicine.

5. How to store Temetex

Temetex does not require any particular precautions for storage. Keep this
medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after Scad. The expiry
date refers to the last day of that month.
The expiry date refers to the product in intact packaging, correctly stored.
Do not use this medicine if you notice visible signs of deterioration.
Medicines should not be disposed of via drains or household waste. Ask your
pharmacist how to dispose of medicines you no longer use. This will help protect
the environment.

6. Contents of the pack and other information

What Temetex contains
100 g of cream contains:

Active substance: diflucortolone valerate 0.3 g.

Other components: white beeswax, liquid paraffin, white petrolatum, dehymuls® E (beeswax,
sorbitan, (Z)-9-octadecenoate (2:3), C12-18 fatty acid, mixed esters with citric acid,
pentaerythritol and stearyl alcohol), purified water.

Description of the appearance of Temetex and contents of the pack
Temetex 3mg/g hydrophobic cream is presented in a 20 g tube containing white cream.

Marketing authorisation holder and manufacturer

Marketing authorisation holder
TEOFARMA S.r.l.
Via F.lli Cervi, 8
27010 Valle Salimbene (PV)
Pro ducer
Teofarma S.r.l.
Viale Certosa, 8/A
27100 Pavia